ID
23002
Description
Study ID: 100527 Clinical Study ID: B2E100527 Study Title: A randomised, double blind, placebo controlled, parellel group study to examine the efficacy, safety, tolerability and systemic pharmacokinetic profile of repeated inhaled doses of GSK159797 Sponsor: GlaxoSmithKline Phase: phase 2 Study Recruitment Status: Completed Generic Name: milveterol Trade Name: Milveterol Study Indication: Pulmonary Disease, Chronic Obstructive
Keywords
Versions (1)
- 6/19/17 6/19/17 -
Uploaded on
June 19, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Status of Treatment Blind - GSK Milveterol COPD 100527
Status of Treatment Blind - GSK Milveterol COPD 100527
- StudyEvent: ODM
Similar models
Status of Treatment Blind - GSK Milveterol COPD 100527
- StudyEvent: ODM
C0449438 (UMLS CUI-2)
C2347038 (UMLS CUI [1,2])
C3897431 (UMLS CUI [1,2])
C3897431 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C3897431 (UMLS CUI [1,3])
No comments